ATE213937T1 - Spezielle halofantrinhaltige zusammensetzungen - Google Patents
Spezielle halofantrinhaltige zusammensetzungenInfo
- Publication number
- ATE213937T1 ATE213937T1 AT95915852T AT95915852T ATE213937T1 AT E213937 T1 ATE213937 T1 AT E213937T1 AT 95915852 T AT95915852 T AT 95915852T AT 95915852 T AT95915852 T AT 95915852T AT E213937 T1 ATE213937 T1 AT E213937T1
- Authority
- AT
- Austria
- Prior art keywords
- halofantrine
- compositions containing
- special compositions
- special
- lipid
- Prior art date
Links
- 229960003242 halofantrine Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- FOHHNHSLJDZUGQ-UHFFFAOYSA-N 3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthrenyl]-1-propanol Chemical compound FC(F)(F)C1=CC=C2C(C(O)CCN(CCCC)CCCC)=CC3=C(Cl)C=C(Cl)C=C3C2=C1 FOHHNHSLJDZUGQ-UHFFFAOYSA-N 0.000 title 1
- FOHHNHSLJDZUGQ-VWLOTQADSA-N Halofantrine Chemical compound FC(F)(F)C1=CC=C2C([C@@H](O)CCN(CCCC)CCCC)=CC3=C(Cl)C=C(Cl)C=C3C2=C1 FOHHNHSLJDZUGQ-VWLOTQADSA-N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9406858A GB9406858D0 (en) | 1994-04-07 | 1994-04-07 | New use and formulations |
| GB9416404A GB9416404D0 (en) | 1994-08-13 | 1994-08-13 | New use and formulations |
| PCT/EP1995/001257 WO1995027492A1 (en) | 1994-04-07 | 1995-04-04 | Halofantrine free base for the treatment of malaria and compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE213937T1 true ATE213937T1 (de) | 2002-03-15 |
Family
ID=26304653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95915852T ATE213937T1 (de) | 1994-04-07 | 1995-04-04 | Spezielle halofantrinhaltige zusammensetzungen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5968987A (de) |
| EP (1) | EP0754045B1 (de) |
| JP (1) | JPH09512794A (de) |
| CN (1) | CN1145030A (de) |
| AT (1) | ATE213937T1 (de) |
| AU (1) | AU685263B2 (de) |
| BR (1) | BR9507437A (de) |
| CA (1) | CA2187185A1 (de) |
| CZ (1) | CZ293696A3 (de) |
| DE (1) | DE69525740T2 (de) |
| ES (1) | ES2170143T3 (de) |
| HU (1) | HUT76051A (de) |
| NO (1) | NO964238D0 (de) |
| NZ (1) | NZ284068A (de) |
| PL (1) | PL179608B1 (de) |
| WO (1) | WO1995027492A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5340298A (en) * | 1996-12-27 | 1998-07-31 | Takeda Chemical Industries Ltd. | Stabilized tricyclic compound |
| US6979456B1 (en) * | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| IN191696B (de) * | 1999-02-12 | 2003-12-20 | Council Scient Ind Res | |
| US6616942B1 (en) * | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
| US6759058B1 (en) * | 2001-04-25 | 2004-07-06 | Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences | Enteric-coated proliposomal formulations for poorly water soluble drugs |
| AUPR573001A0 (en) * | 2001-06-15 | 2001-07-12 | Glaxo Wellcome Australia Ltd | Lymphatic drug delivery system |
| US7588786B2 (en) * | 2001-11-14 | 2009-09-15 | Jarrow Formulas, Inc. | Eutectic-based self-nanoemulsified drug delivery system |
| US20060148776A1 (en) * | 2003-03-13 | 2006-07-06 | Conforma Therapeutics Corporation | Drug formulations having long and medium chain triglycerides |
| AU2004277951B2 (en) | 2003-09-29 | 2010-11-11 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
| US8124072B2 (en) | 2003-09-29 | 2012-02-28 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
| US20050220866A1 (en) * | 2004-04-02 | 2005-10-06 | Dr. Reddy's Laboratories Limited | Novel capsule formulations of etoposide for oral use |
| US8343541B2 (en) | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
| SA109300195B1 (ar) | 2008-03-28 | 2013-04-20 | Astrazeneca Ab | تركيبة صيدلانية جديدة مضادة للسرطان |
| CA2690490C (en) * | 2010-01-19 | 2012-06-26 | Accucaps Industries Limited | Pharmaceutical formulations of loratadine for encapsulation and combinations thereof |
| US9309136B2 (en) * | 2014-06-12 | 2016-04-12 | Tersus Environmental, Llc | Bioremediation of soil and groundwater |
| KR102397569B1 (ko) * | 2014-06-19 | 2022-05-12 | 솔루랄 파마 에이피에스 | 친유성 화합물의 고형 경구 투여 형태 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4818767A (en) * | 1983-11-02 | 1989-04-04 | Smithkline Beckman Corporation | Quinate salts of antimalarial phenanthrenemethanol compounds |
| US4507288A (en) * | 1983-09-16 | 1985-03-26 | Smithkline Beckman Corporation | β-Glycerophosphate salts of antimalarial phenanthrenemethanol compounds |
| US5278173A (en) * | 1988-06-30 | 1994-01-11 | Davis Michael H | Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo |
| AU2279292A (en) * | 1991-07-15 | 1993-02-23 | Smithkline Beecham Plc | Pharmaceutical formulations comprised of micronised halofantrine |
-
1995
- 1995-04-04 AU AU22568/95A patent/AU685263B2/en not_active Ceased
- 1995-04-04 PL PL95316656A patent/PL179608B1/pl unknown
- 1995-04-04 CZ CZ962936A patent/CZ293696A3/cs unknown
- 1995-04-04 WO PCT/EP1995/001257 patent/WO1995027492A1/en not_active Ceased
- 1995-04-04 CN CN95192440A patent/CN1145030A/zh active Pending
- 1995-04-04 AT AT95915852T patent/ATE213937T1/de not_active IP Right Cessation
- 1995-04-04 BR BR9507437A patent/BR9507437A/pt not_active Application Discontinuation
- 1995-04-04 DE DE69525740T patent/DE69525740T2/de not_active Expired - Fee Related
- 1995-04-04 JP JP7526060A patent/JPH09512794A/ja active Pending
- 1995-04-04 NZ NZ284068A patent/NZ284068A/en unknown
- 1995-04-04 CA CA002187185A patent/CA2187185A1/en not_active Abandoned
- 1995-04-04 ES ES95915852T patent/ES2170143T3/es not_active Expired - Lifetime
- 1995-04-04 HU HU9602740A patent/HUT76051A/hu unknown
- 1995-04-04 EP EP95915852A patent/EP0754045B1/de not_active Expired - Lifetime
-
1996
- 1996-10-04 NO NO964238A patent/NO964238D0/no not_active Application Discontinuation
-
1997
- 1997-10-15 US US08/950,459 patent/US5968987A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69525740D1 (de) | 2002-04-11 |
| CA2187185A1 (en) | 1995-10-19 |
| HU9602740D0 (en) | 1996-11-28 |
| HUT76051A (en) | 1997-06-30 |
| BR9507437A (pt) | 1997-09-16 |
| ES2170143T3 (es) | 2002-08-01 |
| NO964238L (no) | 1996-10-04 |
| EP0754045A1 (de) | 1997-01-22 |
| MX9604611A (es) | 1997-11-29 |
| CN1145030A (zh) | 1997-03-12 |
| AU685263B2 (en) | 1998-01-15 |
| PL316656A1 (en) | 1997-02-03 |
| US5968987A (en) | 1999-10-19 |
| JPH09512794A (ja) | 1997-12-22 |
| AU2256895A (en) | 1995-10-30 |
| PL179608B1 (pl) | 2000-10-31 |
| WO1995027492A1 (en) | 1995-10-19 |
| NZ284068A (en) | 1998-06-26 |
| EP0754045B1 (de) | 2002-03-06 |
| NO964238D0 (no) | 1996-10-04 |
| DE69525740T2 (de) | 2002-10-24 |
| CZ293696A3 (en) | 1997-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69525740D1 (de) | Spezielle halofantrinhaltige Zusammensetzungen | |
| DE69519580D1 (de) | Zahnpflegemitteln | |
| DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
| NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
| NO971889D0 (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| DE60110342D1 (de) | Alpha-Interferon enthaltende Hautpflegemittel | |
| BG101132A (en) | Pyridoanilated thienyl and furanyl oxazolidinons | |
| DE69531204D1 (de) | Formulierungen fuer faktor ix | |
| FI965036A7 (fi) | Interleukiini-beta:aa muuttavan entsyymin inhibiittoreita sekä niitä sisältävät farmaseuttiset koostumukset | |
| DE69811062D1 (de) | Polyaromatische antivirale zusammensetzungen | |
| ATE423562T1 (de) | Alpha-ketoamidhaltige multikatalytische protease inhibitoren | |
| ATE273690T1 (de) | Zusammensetzung zur hautdesinfizierung | |
| SE9802729D0 (sv) | Novel Compounds | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| ATE237633T1 (de) | Analogen des keratinozytenwachstumfaktors | |
| SE9201628D0 (sv) | Pharmaceutical composition | |
| MX9304633A (es) | Composiciones orales. | |
| BG99177A (bg) | Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза | |
| CY1105482T1 (el) | Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων | |
| AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
| RU94038042A (ru) | Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент | |
| AU1815899A (en) | Method and composition to enhance the efficacy of a vaccine using chemokines | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| MXPA03011128A (es) | Composicion de sabor y fragancia. | |
| DK0773782T3 (da) | Terpenderivater (sarcodictyiner) anvendelse som antitumormidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |